Ces Urol 1999, 3(1):35-39

The erythropoetin use in radical prostatectomy

D. Pack, V. Vít, J. Doležel, B. Stíbor, I. Čundrle
Urologická klinika FN Brno-Bohunice ARO FN Brno-Bohunice

The radical prostatectomy belongs to surgical therapy with potential blood loss. The tension towards the minimalisation of risk of alogenous blood application leads to expansion of standardised blood care methods, including preoperative autologous blood donorship (PAD) and acute isovolemic hemodilution (AHD), by the method of red cells production support using erythropoetin alpha. The aim of our study was to evaluate the changes in red blood cells count using the methods of blood treatment mentioned above and to assess the erythropoetin toleration and to reduce the disadvantages and potential risks of standard blood treatment methods.

Keywords: Radical prostatectomy, Blood loss, Blood care methods, Erythropoetin

Published: January 1, 1999 

Open full article

References

  1. Walsh, P.C.: Anatomic radical retropubic prostatectomy.In: Cambell´s Urology, Ed.Walsh, P.C. et al.,1998, s. 2565-2588
  2. Smith, J.A., Bray, W.L.: Surgical techniques to minimize blood loss. Seminary Contemporary techniques of blood management in radical prostatectomy patients. Congress Societe Internationale d´Urologie, Montreal, September 7, 1997.
  3. Monk, T.G., Goodnough, L.T., Brechner, M.E., Pulley, D.D., Colberg, J.W., Andriole, G.L., Catalona, W.J.: Acute normovolemic hemodilution can replace preoperative autologous blood Donation as a standard care for autologous blood procurement in radical prostatectomy. Anest. Analg., 85, 1997, s. 953-958. Go to original source...
  4. Monk, T.G.: Improving the outcome of acute normovolemic hemodilution with epoetin alfa. Semin Hematol, 3, l997, suppl 2, 48.
  5. Sans, T., Bofill, C., Joven, J., Clivillé, X., Simó, J.M., Llobet, X., Peró, A., Galbany, J.: Effectiveness of very low doses of subcutaneous recombinant human erythropoietin in facilitating autologous blood donation before orthopedic surgery. Transfusion, 36, l996, s. 822-826. Go to PubMed...
  6. Avall, A., Hyllner, M., Bengtson, J.P., Carlsson, L., Bengtson, A.: Postoperative inflammatory response after autologous and allogenic blood transfusion. Anesthesiology, 87, l997, s. 5ll-5l6.
  7. Goodnough, L.T., Grishaber, J.E., Birkmeyer, J.D., Monk, T.G., Catalona, W.J.: Efficacy and cost- effectiveness of autologous blood predeposit in patients undergoing radical prostatectomy procedures. Urology, 44, l994, s. 226-23l. Go to PubMed...
  8. Toy, P.T.C.Y., Menozzi, D., Strauss, R.G., Stehling, L.C., Kruskull, M., a Ahn, D.K.: Efficacy of preoperative donation of blood for autologous use in radical prostatectomy. Transfusion, 33, l993, s. 72l-724. Go to PubMed...
  9. Toy, P.T.C.Y., Strauss, R., Stehling, L.C., et. al.: Predeposited autologous blood for elective surgery: a national multicentric study. NEJM, 316, l987, s. 5l7-52O. l0. Yamada, A.H., Lieskovsky, G., Skinner, D.G., Shulman, I., Groshen, S., Chen, S.C.: Impact of autologous blood transfusions on patients undergoing radical prostatectomy using hypotensive anestesia. ll. Goodnough, L.T., Riddell, J., Kursh, F., Resnick, M.I.: Utilization and efficacy of autologous blood predeposit in radical prostatectomy with lymphadenectomy: Implications for blood conservation and physician education programs. Urology, 40, l992, s. 2Ol-2O5.
  10. Milbrink, J., Birgerard, G., Danersund, A., Helmers, C., Nordstrom, L., Sandhagen, B.: Preoperative autologous donation of 6 units of blood during rh - EPO treatment. Can J Anaesth, 44, l997, s. l3l5-l3l8.
  11. Kettelhack, C., Hones, C., Messinger, D., Schalg, P.M.: Randomized multicentre trial of the influence of recombinant human erythropoietin on intraoperative and postoperative need in anaemic patients undergoing right hemicolectomy for carcinoma. British Journal of Surgery, 85, l998, s. 63-67. Go to PubMed...
  12. Faris, P.M., Ritter, M.A., Abler, R.I.: The effects of recombinant human erythropoietin on perioperative transfusion requirements in patients having a major orthopaedic operation. The American Erythropoietin Study Group. J. Bone Joint Surg Am, l996, s. 62-72.
  13. Goldberg, N.A., Mc Cutchen, J.W., Jove, M., Dicesare, P., Friedman, R.J., Pass, R., Gailfoyle, M., Frei, D., Young, D.: A safety and efficacy comparison study of two dosing regimens of Epoetin alfa in patients undergoing major orthopedic surgery. Am J, Orthop, 25, l996, s. 544-552. Go to PubMed...
  14. Canadian Orthopedic Perioperative Erythropoietin Study Group: Effectiveness of perioperative recombinant human erythropoietin in elective hip replacement. Lancet, 341, l993, s. l227-l232.
  15. Goodnough, L.T., Mark, T.G., Andriole, G.L.: Erythropoietin Therapy. NE JM, 336, l997, s. 933-938.
  16. Lindahl, S. G.E.: Acute normovolemic haemodilution. Bailliere´s Clinical Anaesthesiology, l0, l996, s. 7l7-723.
  17. Zollinger, A., Hager, P., Singer, T., Friedl, H.P., Pasch, T., Spahn, D.R.: Extreme hemodilution due to massive blood loss in tumor surgery. Anesthesiology, 87, l997, s. 985-987. Go to PubMed...
  18. Monk, T.G., Goodnough, L.T., Birkmeyer, J.D., Brecher, M.E., Catalona, J.W.: Acute normovolemic hemodilution is a cost - effective alternative to preoperative autologous donation in patients undergoing radical retropubic prostatectomy. Transfusion, 35, l995, s. 559-565. Go to PubMed...
  19. Monk, T.G., Goodnough, L.T., Andriole, G.L., Colberg, J.W., Lemon, D.J., Martin, K.J.: Preoperative recombinant human erythropoietin therapy enhances the efficacy of acute normovolemic hemodilution. Anesth. Analg., 8O, l995, s. 32O.
  20. Monk, T. G.: Improving the outcome of acute normovolemic hemodilution with Epoetin Alfa. Seminars in hematology, 33, l996, s. 48-52.

Return to the content



Web časopisu Česká urologie je určen pouze pro lékaře a odborníky
z oblasti medicíny nebo farmacie.



Beru na vědomí, že informace zveřejněné na těchto stránkách
nejsou určeny pro laickou veřejnost.


Odejít Vstoupit